Also found in: Thesaurus, Medical, Wikipedia.
Related to omeprazole: ranitidine, Losec


A proton pump inhibitor drug, C17H19N3O3S, that suppresses gastric acid secretion and is used for the treatment of duodenal and gastric ulcers and gastroesophageal reflux disease.

[Perhaps o(xy)- + me(thyl) + -prazole, antiulcer agent suff. (probably p(ipe)r(idine) + (benzimid)azole).]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.omeprazole - antacid (trade name Prilosec) that suppresses acid secretion in the stomach
alkaliser, alkalizer, antacid, antiacid, gastric antacid - an agent that counteracts or neutralizes acidity (especially in the stomach)


n omeprazol m
References in periodicals archive ?
All patients were treated with 40 mg of omeprazole per day In the otitis media patients, middle ear discharge, granulations, and polyps disappeared in a mean of it weeks.
ZEGERID (omeprazole/sodium bicarbonate) contains omeprazole, a PPI, and sodium bicarbonate, which raises the gastric pH and thus protects omeprazole from acid degradation.
announced today that the United States District Court for the Southern District of New York has ruled that Mylan's 10 mg and 20 mg omeprazole delayed-release capsules, which are the generic versions of AstraZeneca LP's Prilosec (R), do not infringe patents asserted against it by AstraZeneca.
Omeprazole also provided greater symptomatic relief after 5 months of on-demand therapy among those who responded to initial therapy Dr.
None of the patients had any clinical, biochemical, or hematologic abnormalities associated with their omeprazole treatment.
AstraZeneca also contends that physicians exercised their independent medical judgment to prescribe Nexium for numerous patient-specific reasons, that many class members obtained greater relief from their symptoms with Nexium than with Prilosec or omeprazole, and that many saved money by purchasing Nexium instead of Prilosec or omeprazole.
Clopidogrel is marketed as Plavix, and omeprazole is marketed as Prilosec and Prilosec OTC.
One common factor among these patients was that they were both receiving chronic omeprazole therapy.
The patient's dose of omeprazole was increased to 20 mg twice daily, and nizatidine at 300 mg at night was started.
In addition, the 24-hour pH control achieved with the immediate release form of omeprazole in PA32540 should be sufficient for control of gastric acidity in patients taking chronic aspirin therapy for secondary cardiovascular prevention.
Blinding may have been suboptimal due to the nonidentical appearance of the omeprazole placebo control capsule.